Philip Vitticore
Concepts (30)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Biomedical Research | 2 | 2006 | 87 |
Why?
|
Drug Approval | 2 | 2006 | 15 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2006 | 45 |
Why?
|
Research Support as Topic | 2 | 2006 | 27 |
Why?
|
Disease | 1 | 2009 | 27 |
Why?
|
Neurosciences | 1 | 2006 | 3 |
Why?
|
Scopolamine Hydrobromide | 1 | 2005 | 8 |
Why?
|
Cranial Fossa, Posterior | 1 | 2005 | 7 |
Why?
|
Antiemetics | 1 | 2005 | 15 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2005 | 24 |
Why?
|
Amines | 1 | 2005 | 39 |
Why?
|
Vomiting | 1 | 2005 | 45 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2005 | 58 |
Why?
|
Federal Government | 1 | 2009 | 5 |
Why?
|
Government Agencies | 1 | 2009 | 12 |
Why?
|
United States | 2 | 2006 | 604 |
Why?
|
Financing, Government | 1 | 2009 | 16 |
Why?
|
United States Food and Drug Administration | 1 | 2009 | 28 |
Why?
|
Biotechnology | 1 | 2006 | 16 |
Why?
|
Efficiency, Organizational | 1 | 2006 | 25 |
Why?
|
Drug Industry | 1 | 2006 | 18 |
Why?
|
Nervous System Diseases | 1 | 2006 | 78 |
Why?
|
Cholesteatoma | 1 | 2005 | 2 |
Why?
|
Drug Therapy, Combination | 1 | 2005 | 189 |
Why?
|
Time Factors | 1 | 2009 | 896 |
Why?
|
Postoperative Complications | 1 | 2005 | 306 |
Why?
|
Humans | 3 | 2005 | 1858 |
Why?
|
Middle Aged | 1 | 2005 | 1166 |
Why?
|
Animals | 1 | 2006 | 1032 |
Why?
|
Male | 1 | 2005 | 1558 |
Why?
|
